Solid Tumors Harboring NTRK Fusion Completed Phase 1 Trials for Selitrectinib (DB14896)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

IndicationStatusPhase
DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03215511A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat CancerTreatment
NCT04771390Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy ParticipantsOther
NCT04275960Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human BodyBasic Science